Disability Insurance (Belgium) NHF National Health Fund / Myeloma UK / AHTAPol Agency for Health Technology Assessment / National Health Insurance Fund / /
Country
Germany / Netherlands / Italy / Cyprus / Latvia / Sweden / Poland / Norway / Belgium / France / Portugal / Slovakia / United Kingdom / Malta / Lithuania / Finland / Spain / Denmark / Czech Republic / Wales / /
Facility
State Institute of Drug Control / National Institute / INN International Non-proprietary Name MEAs Managed Entry Agreements MS Member States NICE National Institute / NIHDI National Institute of Health / RSA Risk-Sharing Agreement SUKL State Institute / /
IndustryTerm
pharmaceutical / pharmaceuticals / /
MedicalCondition
rare diseases / melanoma / multiple sclerosis / different disease / MS / ADHD / Disease / European multiple sclerosis / /
Organization
Ministry of Social Affairs and Health in Finland / State Institute of Drug Control / DH Department of Health / NHF National Health Fund / Dental and Pharmaceutical Benefits Agency / CC County Council / RSA Risk-Sharing Agreement SUKL State Institute for Drug Control / National Institute for Health and Disability Insurance / National Authority for Medicines and Health / CVZ Health Insurance Board / National Institute for Health / European Union Committee of Experts / Pharmaceutical Benefits Agency / Italian Medicines Agency / Andalusian School of Public Health in Spain / AHTAPol Agency for Health Technology Assessment in Poland / European Commission / EU Commission / European Union / Danish Health and Medicines Authority / Department of Health / NIHDI National Institute of Health / National Health Service / Research PAS Patient Access Scheme PASLU Patient Access Scheme Liaison Unit / Ministry of Health / AIFA Italian Medicines Agency / HTA Health Technology Assessment INFARMED National Authority of Medicines and Health Product / /
Person
Jamie Espìn / Hans Van der Meersch / Isabelle Zahra-Pulis / Alessandra Ferrario / Jakub Adamski / Panos Kanavos April / Kristina Garuoliene / Karl Arnberg / Helena Bowden / Marit Måge / Tina Engraff / Richard Bergström / Jindrich Kotrba / Ellen Vanhaeren / Bruno Costa / Giovanni Tafuri / Helena Katzerová / Edith Frénoy / Paolo Siviero / Pierre Pribile / Jana Ivanova / Anita Viksna / Lauri Pelkonen / Annalisa Sammarco / /
Position
chair of the working group / Directorate-General / EXECUTIVE / Representative / /
Evidence on the impact of managed entries on payers, patients, and manufacturers
[removed]Evidence on the impact of managed entries on payers, patients, and manufacturers